Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

PURPOSE: To validate lysyl oxidase (LOX), a hypoxia-related protein, as a marker for metastasis in an independent head and neck cancer (HNC) patient group enrolled onto a prospective trial. PATIENTS AND METHODS: We performed traditional immunohistochemical (IHC) staining and automated quantitative a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Le, Quynh-Thu, Harris, Jonathan, Magliocco, Anthony M., Kong, Christina S., Diaz, Roman, Shin, Brian, Cao, Hongbin, Trotti, Andy, Erler, Janine T., Chung, Christine H., Dicker, Adam, Pajak, Thomas F., Giaccia, Amato J., Ang, K. Kian
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2009
נושאים:
Original Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744270/
https://ncbi.nlm.nih.gov/pubmed/19667273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.20.6003
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים